Biotechnology Germany’s BioNTech, which has jumped into the limelight from near obscurity through the development of the most successful COVID-19 vaccine (Comirnaty) with US pharma giant Pfizer (NYSE: PFE), today reported financial results for the three months and full year ended December 31, 2021 and provided an update on its corporate progress. 30 March 2022